calendar
7,878 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion
next 91 dayslessmore
MonWedFri
7,878 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion
Therapy area: Central Nervous System, Ear Nose Throat Disorders, Hormonal Disorders, Immunology, Musculoskeletal Disorders, Other Diseases, Women's Health. Indication: Ankylosing Spondylitis (Bekhterev's Disease), Dental Pain (Toothache/Tooth Pain), Fever, Fibromyalgia (Fibromyalgia Syndrome), Gouty Arthritis (Gout), Hyperthyroidism, Laryngitis, Low Back Pain, Mixed Pain (Nociceptive Pain/Neuropathic Pain), Musculoskeletal Inflammation, Musculoskeletal Pain, Myalgia (Muscle Pain), Neuropathic Pa
Therapy area: Oncology. Indication: Small-Cell Lung Cancer
Therapy area: Respiratory. Indication: Streptococcal Pneumonia
Therapy area: Central Nervous System. Indication: Substance (Drug) Abuse
Therapy area: Oncology. Indication: Basal Cell Carcinoma (Basal Cell Epithelioma), Bladder Cancer, Carcinomas, Cervical Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Head And Neck Squamous Cell Carcinoma (HNSC), Lymphoma, Mantle Cell Lymphoma, Melanoma, Non-Hodgkin Lymphoma, Skin Cancer, Solid Tumor, Triple-Negative Breast Cancer (TNBC), Uveal Melanoma
Therapy area: Cardiovascular. Indication: Patent Ductus Arteriosus
Therapy area: Metabolic Disorders. Indication: Diabetes, Obesity, Overweight, Type 2 Diabetes
Therapy area: Central Nervous System. Indication: Smoking Cessation
Therapy area: Immunology. Indication: Inflammation
Therapy area: Oncology. Indication: Adenocarcinoma, Endometrial Cancer, Ovarian Cancer
Therapy area: Cardiovascular, Central Nervous System, Gastrointestinal. Indication: Hypotension, Post Operative Nausea And Vomiting, Post-Operative Pain
Therapy area: Genito Urinary System. Indication: Primary Hyperoxaluria, Primary Hyperoxaluria Type I, Primary Hyperoxaluria Type II, Renal Insufficiency
Therapy area: Metabolic Disorders. Indication: Heterozygous Familial Hypercholesterolemia (heFH), Hypercholesterolemia, Mixed Dyslipidemia
Therapy area: Oncology. Indication: Solid Tumor
Therapy area: Infectious Disease. Indication: Respiratory Syncytial Virus (RSV) Infections
Therapy area: Oncology. Indication: Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis), Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Therapy area: Oncology. Indication: Adenocarcinoma Of The Gastroesophageal Junction, Advanced Malignancy, Bladder Cancer, Esophageal Cancer, Gastric Cancer, Liver Cancer, Malignant Mesothelioma, Non-Small Cell Lung Cancer, Pancreatic Cancer, Solid Tumor
Therapy area: Oncology. Indication: Anaplastic Large Cell Lymphoma (ALCL), Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy, Cutaneous T-Cell Lymphoma, Natural Killer Cell Lymphomas, Peripheral T-Cell Lymphomas (PTCL), T-Cell Leukemia, T-Cell Lymphomas
Therapy area: Oncology. Indication: Cutaneous T-Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome
Therapy area: Oncology. Indication: Breast Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Non-Small Cell Lung Cancer, Solid Tumor
Therapy area: Immunology. Indication: Inflammation
Therapy area: Oncology. Indication: Colorectal Cancer, Gastric Cancer, Ovarian Cancer, Pancreatic Cancer, Peritoneal Cancer
Therapy area: Oncology. Indication: Metastatic Pancreatic Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma
Therapy area: Central Nervous System. Indication: Musculoskeletal Pain, Post-Operative Pain
Therapy area: Oncology. Indication: Advanced Malignancy, Metastatic Cancer, Solid Tumor
Therapy area: Oncology. Indication: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Anaplastic Large Cell Lymphoma (ALCL), Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy, Cutaneous T-Cell Lymphoma, Natural Killer Cell Lymphomas, Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphomas (PTCL), Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Sezary Syndrome, T-Cell Leukemia, T-Cell Lymphomas, Transformed Mycosis Fungoides
Therapy area: Oncology. Indication: Colorectal Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Solid Tumor
Therapy area: Infectious Disease. Indication: Bacillary Dysentery (Shigellosis)
Therapy area: Cardiovascular. Indication: Cardiovascular Disease, Endothelial Dysfunction
Therapy area: Oncology. Indication: Breast Cancer, Hormone Sensitive Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Metastatic Breast Cancer
Therapy area: Oncology. Indication: Kidney Cancer (Renal Cell Cancer), Ovarian Cancer, Renal Cell Carcinoma
Therapy area: Central Nervous System. Indication: Major Depressive Disorder
Therapy area: Immunology. Indication: Anaphylaxis, Food Allergy, Peanut Allergy
Therapy area: Genito Urinary System. Indication: Renal Insufficiency
Therapy area: Metabolic Disorders. Indication: Obesity
Therapy area: Hematological Disorders. Indication: Hemophilia A (Factor VIII Deficiency)
Therapy area: Central Nervous System. Indication: Huntington Disease, Tardive Dyskinesia
Therapy area: Cardiovascular. Indication: Acute Coronary Syndrome, Congestive Heart Failure (Heart Failure), Deep Vein Thrombosis (DVT), Myocardial Infarction, Pulmonary Embolism, Thromboembolic Disease, Thromboembolism, Thrombosis, Unstable Angina, Venous (Vein) Thrombosis, Venous Thromboembolism
Therapy area: Oncology. Indication: Solid Tumor
Therapy area: Cardiovascular. Indication: Acute Ischemic Stroke
Therapy area: Oncology. Indication: Head And Neck Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Oral Cavity (Mouth) Cancer, Squamous Cell Carcinoma
Therapy area: Infectious Disease. Indication: Unspecified Infectious Diseases
Therapy area: Dermatology. Indication: Atopic Dermatitis (Atopic Eczema)
Therapy area: Central Nervous System. Indication: Treatment Resistant Depression
Therapy area: Dermatology. Indication: Hidradenitis Suppurativa
Therapy area: Oncology. Indication: Prostate Cancer
Therapy area: Gastrointestinal. Indication: Liver Fibrosis
Therapy area: Cardiovascular, Genito Urinary System, Metabolic Disorders. Indication: Cardiovascular Risk Factors, Diabetic Nephropathy, Type 1 Diabetes (Juvenile Diabetes), Type 2 Diabetes
Therapy area: Oncology. Indication: Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis), Myeloproliferative Disorders, Polycythemia Vera
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Refractory Multiple Myeloma, Relapsed Multiple Myeloma